Search results for

Microsoft has reacted angrily to claims that it stole the technology used in its Expedia travel booking service. The allegations come in a suit by internet travel booking company priceline.com.

Federal Circuit claim construction rulings with interesting aspects continue to emerge. Among the most recent ones worthy of note are two which demonstrate a worrisome trend on the part of at least some Federal Circuit judges to focus upon specific claim language rather than determining what the whole claim means.

Pirates beware

Four years after Australia first allowed the filing of novel trade marks, Bill Bennett reviews the state of play in relation to shape and colour registrations

Customs - the INTA's perspective

Singapore is the latest state to adapt its copyright law to improve protection for digital works.

When two patent owners come to blows, it is often impossible to respect national boundaries.

For pharma patent owners, things are suddenly looking brighter in Russia. Following a series of defeats for plaintiffs, on October 18, Pfizer won an injunction against Indian company Dr Reddy's Laboratories prohibiting manufacture and sale of its Stamlo product.

he ECJ decision in Pharmacia & Upjohn v Paranova has been awaited with interest by the pharmaceutical industry. The decision, which was handed down on October 12, offers more hope to pharmaceutical companies in the battle against parallel importers than was expected. The ECJ has found that re-branding by a parallel importer to match the brand used in the country of import (where this differs from the country of export) cannot be challenged by the brand owner if such re-branding is objectively necessary in order that the parallel imported product may be marketed in the country of import.

New legislation governing the use of electronic signatures came into force in Spain in the form of Royal Decree Law 14/1999, on September 18 1999.